SNDX   $24.23  0.96% Market Closed After Close 24.23 0.0

Syndax Pharmaceuticals, Inc.
Total Cash 406.40M
totalCashPerShare 4.761
EBITDA -321.20M
Total Debt 854.00K
quickRatio 6.903
currentRatio 6.986
Total Revenue 16.00M
debtToEquity 0.233
Revenue/Share 0.195
ROA -0.48666
ROE -0.81878
grossProfits
freeCashflow -150.82M
operatingCashflow -258.86M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -7.16616
profitMargins 0.0
enterpriseValue 1.28B
forwardPE -6.077161
floatShares 85.02M
sharesOutstanding 85.10M
sharesShort 10.51M
sharesShortPriorMonth 9.67M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.07%
Short Ratio help_outline 10.60%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 4.32
Price To Book help_outline 4.56
earningsQuarterlyGrowth
netIncomeToCommon -297.06M
trailingEps -3.40%
forwardEps -3.24%
enterpriseToEbitda -3.97
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.96 4Q 2024
institutionsCount 279
lastUpdated Nov. 6, 2024, 5:25 p.m.